Mahil, S., Yates, M., Langan, S., Yiu, Z., Tsakok, T., Dand, N., Mason, K., McAteer, H., Meynell, F., Coker, B., Vincent, A., Urmston, D., Vesty, A., Kelly, J., Lancelot, C., Moorhead, L., Bachelez, H., Bruce, I., Capon, F., Contreras, C., Cope, A., De La Cruz, C., Di Meglio, P., Gisondi, P., Hyrich, K., Jullien, D., Lambert, J., Marzo‐Ortega, H., McInnes, I., Naldi, L., Norton, S., Puig, L., Sengupta, R., Spuls, P., Torres, T., Warren, R., Waweru, H., Weinman, J., Griffiths, C., Barker, J., Brown, M., Galloway, J., Smith, C., & , (2021). risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey. British journal of dermatology, 185, 80–90. http://access.bl.uk/ark:/81055/vdc_100172214930.0x00004f